Kardashian Barker discusses the brand’s latest hair growth and anti-shedding capsule launch, her current post-pregnancy hair ...

KOURTNEY Kardashian is facing backlash after being branded “shameless” over an ill-timed birthday post on Kris Jenner’s birthday. Reality star Kourtney, 45, came under fire for ...

A recent article highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These ...

About The Study: This cross-sectional study of privately insured patients found a more than 2-fold increase in use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter. Key ...

GLP-1 Receptor Agonist Market Size 2024 GLP-1 Receptor Agonist Market is expected to reach USD 55.70 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.1% from 2024 to 2031. BURLINGAME, ...

Eli Lilly’s performance is riding on the success of GLP-1 weight loss and Alzheimer’s treatments. It is especially true for its GLP-1 drugs, which have led to massive gains, with more to come.

That’s where GlucoBoost GLP-1 Booster comes into play. This innovative supplement has garnered attention for its natural approach to weight loss, appealing to those who prefer avoiding synthetic ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds. Prescriptions of this GLP-1 class ...

Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds By Ernie Mundell HealthDay Reporter FRIDAY, Oct. 25, 2024 (HealthDay News) -- As the popularity of GLP-1 meds like Wegovy and ...

The study found a sharp increase in the share of patients who received GLP-1 RAs during the study period, with GLP-1 RA use increasing 132.6% from the last six months of 2022 to the last six ...